MEDTRONIC ACTIVA IMPLANTABLE TREMOR CONTROL SYSTEM UNANIMOUSLY CLEARED BY FDA PANEL FOR UNILATERAL USE; PANEL WANTS MORE DATA ON BILATERAL INDICATION

Medtronic plans to continue to pursue approval of a bilateral indication for its Activa implantable deep brain stimulator despite a rejection of that indication by an FDA advisory panel on March 14.

More from Archive

More from Medtech Insight